Vaccines

06 Jun 2011 Stemline Therapeutics, Inc. Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting
06 Jun 2011 New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival
06 Jun 2011 Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection
02 Jun 2011 Fraunhofer USA CMB Announces Positive Phase 1 Interim Results for Its Plant-Produced H1N1 Influenza Vaccine
01 Jun 2011 GlobeImmune Reports Positive Results for Two Therapeutic Vaccines, GI-4000 and GI-6207
01 Jun 2011 Immunovaccine Announces Immune Results from Phase I Trial for DPX-0907 Therapeutic Cancer Vaccine
01 Jun 2011 Diamyd regains control of diabetes therapy
01 Jun 2011 Profectus BioSciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine
26 May 2011 Medicago announces research collaboration for the development of a VLP vaccine candidate for the prevention of Ebola with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
26 May 2011 Dynavax Completes Phase 3 Study of HEPLISAV(TM)
26 May 2011 Isconova initiates influenza study vaccinations
26 May 2011 Mymetics Realizes Successful Phase I Study With Its Innovative HIV Vaccine MYM-V101
25 May 2011 The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences’ Therapeutic HIV DNA Vaccine
25 May 2011 Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
24 May 2011 ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011
24 May 2011 Paladin Labs Files New Drug Submission for Oralair(TM)
20 May 2011 Celiac Disease Vaccine Shows Promising Results in Phase I Trial
19 May 2011 Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
17 May 2011 DBV Demonstrates Ability of VIASKIN to Administer Allergen via Intact Skin by Targeting Dendritic Cells for Safe Treatment of Allergic Disease
10 May 2011 FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
09 May 2011 Pfizer’s Prevnar 13 Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today
09 May 2011 Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study
09 May 2011 Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
09 May 2011 ImmusanT Reports Positive Results from Nexvax2 Phase 1 Study in Celiac Disease
06 May 2011 KAEL-GemVax: TeloVac Becomes World’s Largest Ever Pancreatic Cancer Vaccine Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top